|
|
|
|
|
By Dan Schell, Chief Editor, Clinical Leader | Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials. |
|
|
|
| Developmental Testing Of IV Solutions | Article | By Ryan Memmer, Singota Solutions | As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration. |
|
|
|
|
| IMP Labeling: EU CTR Transition Considerations | Article | TransPerfect | Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies. |
|
|
|
|
|
.png){kind=logo}
